Click here to read the articles and download the PDF
Pharma Pulse 7/25/24: CrowdStrike Explains What Went Wrong Days After Global Tech Outage, The Future of Biosimilars & more
The latest news for pharma industry insiders.
Driving CAR-Ts for Treatment in Cancer and Immunology
A deep dive into why this therapy has demonstrated effectiveness in various areas, including for tumors.
Scorpius to Unveil First Mammalian cGMP Campaign at Texas Plant
The San Antonio facility will be taking this biomanufacturing initiative by the end of Q3 2024.
Pharma Pulse 7/24/24: Addressing OUD Treatment Gaps, Body Dysmorphic Disorder Most Common in Adolescent Girls & more
Agilent Purchases Biovectra for $925 Million
The deal exponentially grows the CDMO’s biopharma capabilities.
Grünenthal Obtains Valinor Pharma
In a transaction valued at $250 million, the deal makes Grünenthal the new owner of Movantik, which treats OIC in adult patients with chronic non-cancer pain.
Pharma Pulse 7/23/24: The Data That Powers AI is Disappearing Fast, Stay Aware of Common High-Alert Medications & more
Does Medicare Properly Cover End-of-Life Care for All Beneficiaries?
Investigators evaluate differences in end-of-life care between Medicare beneficiaries in Medicare Advantage vs. traditional Medicare.
Bridging the Divide: Understanding Contrasting Approaches in Drug Development
Analyzing the divergent paths undertaken by small biotech and large pharma companies in drug development.
Pharma Pulse 7/22/24: Global Diabetes & Obesity Therapeutics Study, Is There a Correlation Between Medical Debt and Delayed Mental Health Care? & more
Susvimo Demonstrates Sustained Efficacy Over Two Years in Patients with Diabetic Macular Edema and Diabetic Retinopathy
FDA to review one-year results for Susvimo showing non-inferior visual acuity gains in diabetic macular edema and in the Diabetic Retinopathy Severity Scale for Diabetic Retinopathy.
Perks of Routing Tests Directly to Physicians’ Offices
In an interview with Pharma Commerce editor Nicholas Saraceno, Matthew Walsh, ixlayer’s manager of biopharma, dives into efficiencies presented by at-home diagnostic tests.
Pharma Pulse 7/19/24: GE HealthCare Agrees to Acquire Clinical AI Business, Essential Approaches for Effective Brand Narratives & more
Sentiments Surrounding At-Home Diagnostic Testing
In an interview with Pharma Commerce editor Nicholas Saraceno, Matthew Walsh, ixlayer’s manager of biopharma, discusses findings of a new physician survey that the company conducted.
Systech, Praxis Packaging Strike Track-and-Trace Partnership
The agreement revolves around providing and maintaining supply chain transparency.
Pharma Pulse 7/18/24: Stigma, Price Point Major Obstacles for Widespread OTC Naloxone Use, RedBox Rx Launches Online Talk Therapy Services & more
Cordenpharma Invests $984 Million into Its Peptide Tech Platform
The financial commitment includes a pair of expansion plans occurring in the United States and Europe.
Improving Cross-Industry Collaboration on Drug Discount Programs
How teamwork among safety-net healthcare providers and pharma can make the difference.
Pharma Pulse 7/17/24: OpenAI Scale Ranks Progress Toward ‘Human-Level’ Problem Solving, Increased Use of GLP-1 Drugs Adds to Navitus’ Drug Spend & more
Upperton Pharma Solution Passes MHRA Inspection, Simultaneously Invests in Large-Scale Processing
The 50,000 square-foot facility has the ability to handle various batch sizes and dosage forms.
Catalent Finalizes Schorndorf Plant Development Project
The clinical supply facility undergoes a $25 million expansion, welcoming 32,000 more square feet of temperature-controlled storage.
Pharma Pulse 7/16/24: Universities Don’t Want AI Research to Leave Them Behind, The AI Revolution Comes to Pharmacy & more
Treating Rheumatoid Arthritis Patients With Biosimilars Versus Leflunomide: An Economic Evaluation
A study explores the cost-effectiveness of combining methotrexate with various drugs as a way to combat failed methotrexate monotherapy.
INCOG BioPharma Invests in Second Manufacturing Building on Indiana Campus
The construction of 100,000 square-foot facility will boost the site's filling capacity to 140 million units per year.
Pharma Pulse 7/15/24: What to Know About Medication and Summer Travel, The Future of Periodontal Treatment & more
